Close Menu

NEW YORK (GenomeWeb) – Somalogic said today it has licensed GNS Healthcare's REFS (Reverse Engineering & Forward Simulation) causal machine learning technology.

Somalogic said it will use the REFS technology to analyze protein datasets generated by its SomaScan proteomic platform to convert them into information that can be used in meaningful ways to manage health at the individual and population levels.

Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.